
Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Migraine could be considered a clinical marker of increased obstetric risk in pregnant women.

Bone marrow transplant could effectively change the brain’s blood vessels from abnormally narrowing.

Worse cases of periodontitis demonstrate association with progression of the scarring of the heart’s left atrium, data indicate.

Data show pharmacist-led clinical consultations can improve patient adherence to medication plans.

The economic burden of symptoms of major depressive disorder were estimated to cost $326 billion for the United States in 2018 alone.

Your pharmacy’s bottom line needs a smarter pricing system to keep up with a tech-smart customer. But when should you make the move?

The knowledge of clinical pharmacists can help protect kidney function and prevent the development of acute kidney injury in ICU patients.

The approval is for the youngest patient population with hereditary angioedema to date.

Patients with triple-negative breast cancer treated with veliparib had statistically significantly longer survival than those given placebo.

In a clinical trial program, 92% of health care providers, patients, and caregivers were able to successfully administer tezepelumab-ekko both in the clinic and at home for severe asthma.

Ultra-processed food consumption linked to an increased risk of developing and dying from ovarian cancer and breast cancer.

Belimumab was the first and only approved biologic for active systemic lupus erythematosus and lupus nephritis in more than 50 years, including for pediatric patients.

Participants also generally prefer newer injectable pre-exposure prophylaxis compared to pills for HIV prevention.

Study findings mark the first evidence of improved health-related quality of life scores following treatment with an investigational microbiome agent in patients with recurrent Clostridioides difficile.

The film traces the rise and fall of identical twin brothers Chris and Jeff George, who trafficked more than $500 million in opioid pills from their clinics.

Specialty medication has grown to about 55% of net spending, which is up by 28% since 2011 mostly driven by autoimmune diseases and oncology.

There are many pharmacy pioneers, both known and unknown, but here we spotlight standouts who made early contributions to the profession.

Sacituzumab govitecan-hziy (Trodelvy) is a conjugated Trop-2-directed antibody and topoisomerase inhibitor previously approved for patients with triple-negative breast cancer.

Biosimilars, staffing issues, and mail-order companies are key trends to watch.

Tracey McGrath, PharmD, pharmacy manager at Sam’s Club, shares strategies to continue exploring art and play as an adult with a busy professional life to help maintain mental and emotional wellbeing.

Availability of TNF-alpha inhibitor biosimilars in Southern European markets led to lowered costs within the drug class, even after an increased consumption volume for these therapies.

Peripheral artery disease is more common in Black patients than any other racial or ethnic group, but its potential association with negative social determinants of health is not known.

Study shows a statistically significant improvement in inflammatory syndrome after a fecal microbiota transplant in patients coinfected with COVID-19 and clostridioides difficile.

The CBD gummy market is being fueled by the desire for alternative, natural treatment options.

B12 deficiency is often due to a lack of consumption of vitamin B12 rich foods or malabsorption.

IQVIA report states that appropriate reimbursement for all health care professionals who provide immunization services would encourage their ongoing provision of vaccines.

Mandy Reece, PharmD, CDCES, BC-ADM, BCACP, FADCES, vice chair and associate professor in the department of pharmacy practice at Philadelphia College of Osteopathic Medicine, discusses diabetes care, change in treatment, and management.

Artificial intelligence technology is integrated into the services and products we use every day in our personal and professional lives.

Results from the phase 2 and long-term trials will be presented later this year, following further data collection.

Bausch + Lomb Corporation and Modulight anticipate that ML6710i will be available for eye care professionals during the first half of 2023.